Fund your research
Each university has a dedicated grant support team. They provide tailored support for research grant applications. This concerns both individual and consortium applications for national as well as international research grants. The level of support varies per institute, but in general includes:
- Advice on application for national and international grants
- Communicating opportunities and linking grant criteria to researchers’ profiles
- Advice on consortium formation
- Providing feedback on proposals and rebuttals
- Interview training
- Post-evaluation analysis
Please visit the respective websites for more information and details on how to contact your dedicated grant support team:
- AMC Research Office, intranet AMC
- HvA Grant Support Team – part of IXA HVA, intranet mijnhva
- UvA Grant Support Team – part of IXA UvA
- VU & VUmc Grant Desk, intranet VU and intranet VUmc
Societal Impact and Knowledge Utilisation
Many grant applications, such as Horizon 2020, require paragraphs on Societal Impact and Knowledge Utilisation. These describe how your research results will benefit society or how they can be useful for companies or public organisations (e.g., museums, charities, governments), and how you will collaborate with these parties to transfer your knowledge. The grant support teams cooperate with the IXA business developers mentioned above, to help you with those paragraphs.
Consortium and Research Collaboration Agreements
In order to facilitate researchers applying for research grants, we additionally offer the support of our legal team. They can assist you with Consortium and Research Collaboration Agreements.
Optics11 and Optics11 Life secure funding to accelerate growth
Optics11 and Optics11 Life have secured funding from Rabobank. The funding will be used to strongly accelerate growth across global markets, to further build the team for the future and to strategically expand the high-tech product portfolios of both business units. “This is the right moment to pick up the pace. Rabobank’s funding helps us […]
News
Azafaros enters clinical stage with AZ-3102, an oral small molecule being developed for rare neurogenetic disorders
Azafaros B.V. announced today that the first cohort of healthy subjects has been dosed in a two-part Phase 1 clinical study with clinical candidate AZ-3102, a first-in-class small molecule compound being developed for the treatment of rare neurogenetic disorders. This double-blind, placebo-controlled, Phase 1 study is evaluating the safety and tolerability of ascending single- (SAD) […]
News
Start-up Cupplement receives investment in TV program Dragons Den
Is it possible to create a cup of coffee that’s healthy and tasty? At the entrepreneurship laboratory Demonstrator Lab at the Vrije Universiteit, Florian Fermin (27) and Stefan Wateler (26) developed Cuppelement, a Fairtrade biodegradable coffee capsule with added superfoods and vitamins. During the Dutch TV program Dragons Den, the entrepreneurs successfully persuaded the dragons […]
News